| Date | Time | Source | Announcement |
|---|---|---|---|
| 09 Mar 2015 | 07:00 AM | Trading Statement | |
| 01 Dec 2014 | 03:15 PM | Directorate Change | |
| 28 Nov 2014 | 07:00 AM | SysQuant - Update/Contract Awards | |
| 19 Nov 2014 | 05:08 PM | Holding(s) in Company | |
| 12 Nov 2014 | 07:00 AM | Trading Update | |
| 16 Oct 2014 | 07:00 AM | Directorate Change | |
| 01 Oct 2014 | 03:54 PM | Director/PDMR Shareholding | |
| 30 Sep 2014 | 07:01 AM | Blocklisting Interim Review | |
| 30 Sep 2014 | 07:00 AM | Directorate Change | |
| 30 Sep 2014 | 07:00 AM | Half Yearly Report | |
| 26 Sep 2014 | 07:00 AM | CK1d Update: Toxicity Results | |
| 25 Sep 2014 | 10:08 AM | Contract with Genting TauRx Diagnostic Centre | |
| 15 Sep 2014 | 07:00 AM | Science and Technology Award | |
| 19 Aug 2014 | 07:00 AM | Appointment of Joint Broker | |
| 08 Jul 2014 | 05:45 PM | Director/PDMR Shareholding | |
| 08 Jul 2014 | 07:00 AM | Alzheimer's blood test study | |
| 01 Jul 2014 | 07:00 AM | Directorate Change | |
| 30 Jun 2014 | 04:42 PM | Result of AGM | |
| 09 Jun 2014 | 04:18 PM | Annual Financial Report | |
| 29 May 2014 | 07:00 AM | Preliminary results | |
| 01 Apr 2014 | 07:00 AM | Blocklisting Interim Review | |
| 27 Mar 2014 | 07:00 AM | Pancreatic Cancer Study in PLOS ONE | |
| 03 Mar 2014 | 04:25 PM | Directorate Change | |
| 28 Feb 2014 | 03:46 PM | Holding(s) in Company | |
| 24 Feb 2014 | 07:00 AM | Placing | |
| 07 Feb 2014 | 07:00 AM | Trading Update | |
| 03 Feb 2014 | 04:44 PM | Holding(s) in Company | |
| 27 Dec 2013 | 04:35 PM | Price Monitoring Extension | |
| 04 Dec 2013 | 07:00 AM | Trading Update | |
| 20 Nov 2013 | 07:00 AM | Patient Stratification Biomarkers for Liver Cancer | |
| 06 Nov 2013 | 02:51 PM | Holding(s) in Company | |
| 01 Oct 2013 | 10:34 AM | Blocklisting Interim Review | |
| 30 Sep 2013 | 07:00 AM | Half Yearly Report | |
| 18 Sep 2013 | 02:00 PM | Key Assay Development at HUPO | |
| 02 Sep 2013 | 12:12 PM | Holding(s) in Company | |
| 06 Aug 2013 | 12:36 PM | Issue of Equity | |
| 18 Jul 2013 | 07:00 AM | New Data Shows CK1d Blocks Tau in AD Model | |
| 28 Jun 2013 | 01:00 PM | AGM Statement | |
| 28 Jun 2013 | 07:00 AM | Patent Statement | |
| 26 Jun 2013 | 09:27 AM | Holding(s) in Company | |
| 12 Jun 2013 | 07:00 AM | Major technology contract | |
| 05 Jun 2013 | 04:08 PM | Annual Financial Report | |
| 30 May 2013 | 07:01 AM | Preliminary Results | |
| 19 Apr 2013 | 07:00 AM | Trading Update | |
| 02 Apr 2013 | 07:00 AM | Block admission return | |
| 18 Mar 2013 | 07:00 AM | Developments in Alzheimer's Disease | |
| 22 Jan 2013 | 07:00 AM | Trading Statement | |
| 31 Dec 2012 | 07:00 AM | CK1D Update | |
| 03 Dec 2012 | 11:06 AM | Holding(s) in Company | |
| 28 Sep 2012 | 07:00 AM | Half Yearly Report |
Proteome Sciences PLC is protein biomarker research and development. The company uses high sensitivity proprietary techniques to detect and characterize differentially expressed proteins in diseases for prognostic and therapeutic applications.
It listed on AIM in 1996 under the ticker PRM.